Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect Discussions

▴ Assessing Covishield Safety
While acknowledging rare side effect concerns, the data showcases the vaccine's significant benefits in combating COVID-19.

In recent developments, AstraZeneca has made the decision to globally withdraw the Oxford-AstraZeneca COVID-19 vaccine due to concerns over rare side effects. This announcement comes weeks after the company acknowledged potential risks associated with the vaccine. Amidst these concerns, studies conducted in India shed light on the overall safety and benefits of the Covishield vaccine.

Covishield Safety Insights from Indian Studies

Researchers from Assam Medical College Hospital, supported by an ICMR-recognised lab, undertook a year-long study to evaluate the safety profile of Covishield. The findings are promising, indicating that 55% of individuals who received Covishield experienced only mild side effects like fever and headache within a week of their first dose. Importantly, the study found no evidence of long-term adverse effects beyond the study period.

Addressing Concerns about Thrombosis with Thrombocytopenia Syndrome (TTS)

Despite these positive findings, concerns have been raised about a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). AstraZeneca acknowledged this potential risk during a UK court case involving their COVID-19 vaccine, which is marketed as Covishield in India and was developed in collaboration with the University of Oxford.

Rare Occurrence of TTS

The Indian studies emphasize that TTS is an exceptionally rare occurrence. While any potential adverse reaction is understandably concerning for patients, it's important to note the significantly positive impact Covishield has had in reducing COVID-19 hospitalizations, critical care needs, and preventing deaths.

Key Insights and Future Considerations

It's crucial to recognize that instances of TTS typically occur within the first four weeks post-vaccination and are identifiable with early detection. The encouraging data from these Indian studies highlight the importance of considering the overall benefits of Covishield against the backdrop of rare side effect concerns.

While these studies provide valuable insights into Covishield's safety, it remains essential to stay updated with ongoing research and recommendations from health authorities. Monitoring and addressing any potential risks associated with COVID-19 vaccines are paramount to ensuring public health and safety.

In conclusion, the recent Indian studies provide encouraging evidence regarding the safety profile of Covishield. While acknowledging rare side effect concerns, the data showcases the vaccine's significant benefits in combating COVID-19. Continued vigilance and informed decision-making will be crucial as we navigate through this shocking turn of events.

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Dangers of Ultra-Processed Foods: A Wake-Up Call for Health Conscious IndiansMay 23, 2024
Can Intermittent Fasting Protect Against Liver Cancer? Here’s What the Science SaysMay 23, 2024
Easier, Faster Claims: The Impact of the National Claim Exchange PortalMay 23, 2024
Can Nightmares Predict Autoimmune Flares? Insights from a Groundbreaking StudyMay 23, 2024
Does Parent-Led Singing Improve Development in Preterm Infants? A Comprehensive StudyMay 22, 2024
Biohacking 101: Boosting Physical and Mental Well-beingMay 22, 2024
In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024